Press Releases

05.26.2021

Myovant Sciences and Pfizer Receive FDA Approval for MYFEMBREE®, the First Once-Daily Treatment for Heavy Menstrual Bleeding Associated With Uterine Fibroids

05.24.2021

Pfizer Initiates Study Exploring Coadministration of Its 20-valent Pneumococcal Conjugate Vaccine Candidate Along With a Third Dose of the Pfizer-BioNTech COVID-19 Vaccine in Older Adults

05.20.2021

Pfizer and BioNTech to Supply the European Union With up to 1.8 Billion Additional Doses of COMIRNATY®

05.10.2021

Pfizer and BioNTech Receive First U.S. Authorization for Emergency Use of COVID-19 Vaccine in Adolescents

05.07.2021

Pfizer and BioNTech Initiate Rolling Submission of Biologics License Application for U.S. FDA Approval of Their COVID 19 Vaccine

05.06.2021

Pfizer and BioNTech to Provide COVID-19 Vaccine Doses for Olympic Athletes at the 2020 Tokyo Games

05.04.2021

PFIZER REPORTS STRONG FIRST-QUARTER 2021 RESULTS

04.28.2021

Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference

04.28.2021

Pfizer Acquires Amplyx Pharmaceuticals

04.28.2021

Pfizer Acquires Amplyx Pharmaceuticals

04.22.2021

Pfizer Declares Second-Quarter 2021 Dividend

04.19.2021

Pfizer and BioNTech to Supply the European Union with 100 Million Additional Doses of COMIRNATY®